ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2025, Vol. 34 ›› Issue (5): 464-469.DOI: 10.3969/j.issn.1006⁃298X.2025.05.013

• 肾脏病基础 • 上一篇    下一篇

免疫检查点分子 B7⁃1 与程序性细胞死亡蛋白⁃配体 1 在足细胞损伤中的交叉作用

  

  • 出版日期:2025-10-28 发布日期:2025-10-30

The crosstalk of B7 homolog 1 and programmed death⁃ligand 1 in podocyte injury

  • Online:2025-10-28 Published:2025-10-30

摘要: 肾病综合征是以大量蛋白尿为特征的临床综合征,其全球发病率持续上升,当前治疗主要依赖糖皮质激素及免疫抑制剂,但部分患者易出现激素抵抗或复发。足细胞损伤是肾病综合征蛋白尿产生的核心机制。近年来,免疫检查点分子 B7⁃1(CD80)和程序性细胞死亡蛋白⁃配体 1(PD⁃L1)在足细胞中的功能备受关注,尤其是二者在足细胞表面发生的顺式结合关注度与日俱增。本文通过系统阐述 B7⁃1 和 PD⁃L1 的分子基础、作用机制、顺式结合反应机制及相关靶向治疗的研究进展,为肾病综合征的精准免疫治疗提供崭新视角,推动相关机制研究向临床应用转化。


关键词: 肾病综合征, 免疫检查点分子 B7?1, 程序性细胞死亡蛋白?配体 1, 顺式结合

Abstract: Nephrotic syndrome (NS) is a clinical syndrome characterized by massive proteinuria. With its global incidence steadily rising, current therapeutic strategies primarily rely on glucocorticoids and immunosuppressants. However, a subset of patients is prone to developing steroid resistance or experiencing disease relapse. Podocyte injury represents the core mechanism underlying proteinuria in NS. In recent years, significant attention has focused on the functions of immune checkpoint molecules B7⁃1 and PD⁃L1 in podocytes, with growing interest in their cis⁃interaction on the podocytes surface. This review systematically elaborates on the molecular basis, mechanisms of action, cis⁃interaction mechanisms, and recent advances in targeted therapies related to B7⁃1 and PD⁃L1. It provides novel insights into precision immunotherapy for NS, thereby facilitating the translation of mechanistic research into clinical applications.


Key words: nephrotic syndrome, B7 homolog 1, programmed death?ligand 1, cis?interaction